LeadIQ logo
Learn more at LeadIQ.com
ImmunoMet Therapeutics, Inc. logo

ImmunoMet Therapeutics, Inc. Employee Directory

Biotechnology ResearchTexas, United States2-10 Employees

ImmunoMet Therapeutics, Inc. is a clinical-stage biotechnology company focused on targeting cellular metabolism to develop therapies for fibrosis and cancer. Its lead program, IM156, is a protein complex 1 inhibitor that disrupts the mitochondrial oxidative phosphorylation pathway to slow abnormal cell growth in fibrotic tissue and in certain cancers. IM156 has completed Phase 1 with favorable tolerability, and the company has outlined plans to advance to a Phase 2 proof-of-concept study in idiopathic pulmonary fibrosis. The organization operates within the biotechnology research arena, concentrating on anti-fibrotic and anti-tumor indications. Based in Houston, Texas, ImmunoMet was founded in 2015 as a spin-off from HanAll Biopharma, a Korean midsized public company, and maintains a relatively small team. In November 2022, the company announced that the first patient had been dosed in a Phase 1b trial of IM156 in combination with gemcitabine and nab-paclitaxel for frontline treatment of advanced pancreatic cancer.

Find ImmunoMet Therapeutics, Inc. employees' phone numbers or email addresses

ImmunoMet Therapeutics, Inc. Global Highlights

Location
Employees

North America
11

Minus sign iconPlus sign icon
  • United States Of America
    11

ImmunoMet Therapeutics, Inc.'s Leadership

  • Stylized image of a person
    W.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. K.
    Chief Executive Officer (chief Executive Officer)
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. B.
    Consulting Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. C.
    Co-Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. C.
    Board Director
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. S. K.
    Bod
    Phone icon
    Mobile Phone

ImmunoMet Therapeutics, Inc. Employee Metrics

100%
50%
0%
2026
2025
  • Business
  • Entrepreneurship
  • Accounting
  • Administrative
  • Analytics
  • Other
  • Biotechnology

Contact profiles from ImmunoMet Therapeutics, Inc.

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    W.
    Chief Executive Officer
    Phone icon
    Mobile Phone
    United StatesMichigan
    Mar 24, 2026
  • Stylized image of a person
    M. B.
    Consulting Chief Financial Officer
    Phone icon
    Mobile Phone
    United StatesNew Jersey
    Apr 15, 2026
  • Stylized image of a person
    T. C.
    Co-Chief Executive Officer
    Phone icon
    Mobile Phone
    United StatesMichigan
    Apr 15, 2026
  • Stylized image of a person
    S. K.
    Chief Executive Officer (chief Executive Officer)
    Phone icon
    Mobile Phone
    Oct 23, 2024
  • Stylized image of a person
    B. C.
    Board Director
    Phone icon
    Mobile Phone
    United StatesMississippi
    Mar 25, 2026
  • Stylized image of a person
    S. S. K.
    Bod
    Phone icon
    Mobile Phone
    Dec 31, 2025

Frequently Asked Questions

What is ImmunoMet Therapeutics, Inc. known for?

Minus sign iconPlus sign iconImmunoMet Therapeutics, Inc. was founded in 2015 operates in the Biotechnology Research industry. The company's main headquarters is located in 2450 Holcombe Boulevard Houston, Texas 77021 United States. Explore ImmunoMet Therapeutics, Inc.'s company overview page for more information.

What is ImmunoMet Therapeutics, Inc.'s most common email format?

Minus sign iconPlus sign iconImmunoMet Therapeutics, Inc. employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more ImmunoMet Therapeutics, Inc. email formats with LeadIQ.

How many employees does ImmunoMet Therapeutics, Inc. have currently?

Minus sign iconPlus sign iconImmunoMet Therapeutics, Inc. has approximately 6 employees as of June 2026. These team members are located across 1 continents, including North America.

Who are ImmunoMet Therapeutics, Inc.'s key employees and leadership?

Minus sign iconPlus sign icon

As of June 2026, ImmunoMet Therapeutics, Inc.'s key employees include:

  • Chief Executive Officer: W.
  • Chief Executive Officer (chief Executive Officer): S. K.
  • Consulting Chief Financial Officer: M. B.
  • Co-Chief Executive Officer: T. C.
  • Board Director: B. C.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

  • B2B data verified in real-time
  • Sync data to your CRM, & add it to an outreach sequence in one click
  • Integrations with your tech stack for optimal efficiency
  • A patented AI cold email generator
  • Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.